$RNXT
RenovoRx, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
RenovoRx, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is RNXT down today? It is at $0.952 (-10.29%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNXT spikes, and full due diligence on RNXT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNXT 43 times in the last 30 days. Create a free account to track $RNXT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how RNXT traded in the last session, Friday (last price and move above). Our scanner fired 6 unusual-volume and momentum alerts on RNXT on Friday, peaking at 28.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystAppoints Interventional Oncology Medtech Leader Richard Stark to its Board of Directors, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 20, 2026 · yesterdayA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Prospectus update and an active shelf on file: the company can issue new shares
8,438,790 new shares · About $10.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Agah Ramtin Officer | Bought (open market) | +50K 0.1% of company | added 6.3% | 848K | $47K at $0.930 | Nov 16, 26 |
Voll Mark Officer | Acquired (grant/award) | +80K 0.2% of company | added 56% | 222K | n/a | Sep 10, 26 |
Voll Mark Officer | Bought (open market) | +25K 0.05% of company | added 21% | 142K | $20K at $0.790 | May 19, 26 |
Voll Mark Officer | Acquired (grant/award) | +80K 0.2% of company | added 100% | 117K | n/a | Apr 3, 26 |
Voll Mark Officer | Acquired (grant/award) | +12K 0.03% of company | added 50% | 37K | n/a | Mar 25, 26 |
Bagai Shaun Officer | Acquired (grant/award) | +24K 0.05% of company | added 8.4% | 313K | n/a | Mar 20, 26 |
Marton Laurence Director | Acquired (grant/award) | +10K 0.02% of company | n/a | 10K | n/a | Mar 20, 26 |
Voll Mark Officer | Acquired (grant/award) | +97K 0.2% of company | n/a | 97K | n/a | Mar 20, 26 |
Agah Ramtin Officer | Bought (open market) | +10K 0.02% of company | added 1.3% | 798K | $10K at $1.00 | Jan 21, 26 |
Agah Ramtin Officer | Bought (open market) | +10K 0.02% of company | added 1.3% | 788K | $8K at $0.860 | Dec 31, 25 |
Agah Ramtin Officer | Bought (open market) | +205 | added <0.1% | 779K | $170 at $0.830 | Dec 30, 25 |
Bagai Shaun Officer | Bought (open market) | +5K 0.01% of company | added 1.5% | 340K | $5K at $0.900 | Dec 18, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
The market is closed. Here is how RNXT traded in the last session, Friday (last price and move above). Our scanner fired 6 unusual-volume and momentum alerts on RNXT on Friday, peaking at 28.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
RNXT last traded at $0.952, down 10.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The RNXT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNXT 43 times in the last 30 days.
RNXT (RenovoRx, Inc. Common Stock) trades on XNAS, with a market cap of about $45M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNXT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNXT discussion
Sign in to ask a question or join the discussion.